García Trejo, E.M.Á.; Arellano Buendía, A.S.; Sánchez Reyes, O.; García Arroyo, F.E.; Arguello García, R.; Loredo Mendoza, M.L.; Tapia, E.; Sánchez Lozada, L.G.; Osorio Alonso, H.
The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan. Int. J. Mol. Sci. 2017, 18, 1980.
https://doi.org/10.3390/ijms18091980
AMA Style
García Trejo EMÁ, Arellano Buendía AS, Sánchez Reyes O, García Arroyo FE, Arguello García R, Loredo Mendoza ML, Tapia E, Sánchez Lozada LG, Osorio Alonso H.
The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan. International Journal of Molecular Sciences. 2017; 18(9):1980.
https://doi.org/10.3390/ijms18091980
Chicago/Turabian Style
García Trejo, Ehécatl Miguel Ángel, Abraham Said Arellano Buendía, Omegar Sánchez Reyes, Fernando Enrique García Arroyo, Raúl Arguello García, María Lilia Loredo Mendoza, Edilia Tapia, Laura Gabriela Sánchez Lozada, and Horacio Osorio Alonso.
2017. "The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan" International Journal of Molecular Sciences 18, no. 9: 1980.
https://doi.org/10.3390/ijms18091980
APA Style
García Trejo, E. M. Á., Arellano Buendía, A. S., Sánchez Reyes, O., García Arroyo, F. E., Arguello García, R., Loredo Mendoza, M. L., Tapia, E., Sánchez Lozada, L. G., & Osorio Alonso, H.
(2017). The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan. International Journal of Molecular Sciences, 18(9), 1980.
https://doi.org/10.3390/ijms18091980